{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:24:15Z","timestamp":1787019855976,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12348-017-0124-5","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T07:10:48Z","timestamp":1487142648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS)\u2014report 4: analysis and outcome of scleritis in an East Asian population"],"prefix":"10.1186","volume":"7","author":[{"given":"Muhammad Amir","family":"Bin Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Hui Fen","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Mi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Poh Ying","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Su","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee Kiak","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6662-5850","authenticated-orcid":false,"given":"Rupesh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"124_CR1","first-page":"642","volume-title":"Ocular inflammation and immunity","author":"PJ McCluskey","year":"1996","unstructured":"McCluskey PJ, Wakefield D (1996) Scleritis and Episcleritis. In: Pepose JS, Holland GN, Wilhelms KR (eds) Ocular inflammation and immunity. Mosby, St Louis, pp 642\u2013647"},{"key":"124_CR2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","volume":"50","author":"N Okhravi","year":"2005","unstructured":"Okhravi N, Odufuwa B, McCluskey P et al (2005) Scleritis. Surv Ophthalmol 50:351\u2013363","journal-title":"Surv Ophthalmol"},{"key":"124_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","volume":"60","author":"PG Watson","year":"1976","unstructured":"Watson PG, Hayreh SS (1976) Scleritis and Episcleritis. Br J Ophthalmol 60:163\u2013191","journal-title":"Br J Ophthalmol"},{"key":"124_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0161-6420(94)31325-X","volume":"101","author":"M Sainz de la Maza","year":"1994","unstructured":"Sainz de la Maza M, Jabbur NS, Foster CS (1994) Severity of scleritis and episcleritis. Ophthalmology 101:389\u2013396","journal-title":"Ophthalmology"},{"key":"124_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.iio.0000155900.64809.b2","volume":"45","author":"TA Albini","year":"2005","unstructured":"Albini TA, Rao NA, Smith RE (2005) The diagnosis and management of anterior scleritis. Int Ophthalmol Clin 45:191\u2013204","journal-title":"Int Ophthalmol Clin"},{"key":"124_CR6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0454","volume":"3","author":"JR Smith","year":"2007","unstructured":"Smith JR, Mackensen F, Rosenbaum JT (2007) Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol 3:219\u2013226","journal-title":"Nat Clin Pract Rheumatol"},{"key":"124_CR7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00055735-200112000-00013","volume":"12","author":"CE Pavesio","year":"2001","unstructured":"Pavesio CE, Meier FM (2001) Systemic disorders associated with episcleritis and scleritis. Curr Opin Ophthalmol 12:471\u2013478","journal-title":"Curr Opin Ophthalmol"},{"key":"124_CR8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Mudun A, Dunn JP et al (2000) Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 130:469\u2013476","journal-title":"Am J Ophthalmol"},{"key":"124_CR9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(91)32269-3","volume":"98","author":"SJ Tuft","year":"1991","unstructured":"Tuft SJ, Watson PG (1991) Progression of scleral disease. Ophthalmology 98:467\u2013471","journal-title":"Ophthalmology"},{"key":"124_CR10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2007.09.024","volume":"145","author":"P Lin","year":"2008","unstructured":"Lin P, Bhullar SS, Tessler HH et al (2008) Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol 145:463\u2013471","journal-title":"Am J Ophthalmol"},{"key":"124_CR11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.73.9.743","volume":"73","author":"D Wakefield","year":"1989","unstructured":"Wakefield D, McCluskey P (1989) Cyclosporin therapy for severe scleritis. Br J Ophthalmol 73:743\u2013746","journal-title":"Br J Ophthalmol"},{"key":"124_CR12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0161-6420(92)31790-7","volume":"99","author":"SS Shah","year":"1992","unstructured":"Shah SS, Lowder CY, Schmitt MA et al (1992) Low dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 99:1419\u20131423","journal-title":"Ophthalmology"},{"key":"124_CR13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","volume":"112","author":"EJ Throne","year":"2005","unstructured":"Throne EJ, Jabs DA, Qaiz FA et al (2005) Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 112:1472\u20131477","journal-title":"Ophthalmology"},{"key":"124_CR14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","volume":"111","author":"CC Murphy","year":"2004","unstructured":"Murphy CC, Ayliffe WH, Booth A et al (2004) Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 111:352\u2013356","journal-title":"Ophthalmology"},{"key":"124_CR15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/bjo.2008.147157","volume":"93","author":"S Chauhan","year":"2009","unstructured":"Chauhan S, Kamal A, Thompson RN et al (2009) Rituximab for treatment of scleritis associated with rheumatoid arthritis. Br J Ophthalmol 93:984\u2013985","journal-title":"Br J Ophthalmol"},{"key":"124_CR16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bjo.2008.150961","volume":"94","author":"P Doctor","year":"2010","unstructured":"Doctor P, Sultan A, Syed S et al (2010) Infliximab for the treatment of refractory scleritis. Br J Ophthalmol 94:579\u2013583","journal-title":"Br J Ophthalmol"},{"key":"124_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09273941003739928","volume":"18","author":"B Iaccheri","year":"2010","unstructured":"Iaccheri B, Androudi S, Bocci EB et al (2010) Rituximab treatment for persistent scleritis associated with rheumatoid arthritis. Ocul Immunol Inflamm 18:223\u2013225","journal-title":"Ocul Immunol Inflamm"},{"key":"124_CR18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bjo.2007.133173","volume":"93","author":"PA Kurz","year":"2009","unstructured":"Kurz PA, Suhler EB, Choi D, Rosenbaum JT (2009) Rituximab for treatment of ocular inflammatory disease: a series of four cases. Br J Ophthalmol 93:546\u2013548","journal-title":"Br J Ophthalmol"},{"key":"124_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10067-009-1368-8","volume":"29","author":"JP Restrepo","year":"2010","unstructured":"Restrepo JP, Molina MP (2010) Successful treatment of severe nodular scleritis with adalimumab. Clin Rheumatol 29:559\u2013561","journal-title":"Clin Rheumatol"},{"key":"124_CR20","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3129\/i09-061","volume":"44","author":"HN Sen","year":"2009","unstructured":"Sen HN, Sangave A, Hammel K et al (2009) Infliximab for the treatment of active scleritis. Can J Ophthalmol 44:e9\u2013e12","journal-title":"Can J Ophthalmol"},{"issue":"10","key":"124_CR21","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ophtha.2014.04.044","volume":"121","author":"EB Suhler","year":"2014","unstructured":"Suhler EB, Lim LL, Beardsley RM et al (2014) Rituximab therapy for refractory scleritis: results of a phase I\/II dose-ranging, randomized, clinical trial. Ophthalmology 121(10):1885\u20131891","journal-title":"Ophthalmology"},{"key":"124_CR22","doi-asserted-by":"crossref","first-page":"256e9","DOI":"10.1159\/000310626","volume":"209","author":"N Nakajima","year":"1995","unstructured":"Nakajima N, Hayasaka S (1995) Clinical features of episcleritis and scleritis in some Japanese patients. Ophthalmologica 209:256e9","journal-title":"Ophthalmologica"},{"key":"124_CR23","doi-asserted-by":"crossref","first-page":"275e8","DOI":"10.1159\/000101931","volume":"221","author":"A Anshu","year":"2007","unstructured":"Anshu A, Chee SP (2007) Posterior scleritis and its association with HLA B27 haplotype. Ophthalmologica 221:275e8","journal-title":"Ophthalmologica"},{"key":"124_CR24","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bjo.2009.171744","volume":"94","author":"H Keino","year":"2010","unstructured":"Keino H, Watanabe T, Taki W et al (2010) Clinical features and visual outcomes of Japanese patients with scleritis. Br J Ophthalmol 94:1459\u20131463","journal-title":"Br J Ophthalmol"},{"key":"124_CR25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0161-6420(95)30970-0","volume":"102","author":"M Sainz de la Maza","year":"1995","unstructured":"Sainz de la Maza M, Foster CS, Jabbur NS (1995) Scleritis associated with systemic vasculitic diseases. Ophthalmology 102:687\u2013692","journal-title":"Ophthalmology"},{"key":"124_CR26","first-page":"192e226","volume":"60","author":"DDM McGavin","year":"1976","unstructured":"McGavin DDM, Williamson J, Forrester JV et al (1976) Episcleritis and scleritis. A study of their clinical manifestation and association with rheumatoid arthritis. Br J Ophthalmol 60:192e226","journal-title":"Br J Ophthalmol"},{"key":"124_CR27","first-page":"1075e8","volume":"41","author":"K Araki","year":"1987","unstructured":"Araki K, Nakagawa Y, Tada R et al (1987) Clinical features of 75 cases of scleritis during the past 11\u00a0years. Jpn J Clin Ophthalmol 41:1075e8","journal-title":"Jpn J Clin Ophthalmol"},{"key":"124_CR28","first-page":"797e803","volume":"45","author":"H Kurosaka","year":"1994","unstructured":"Kurosaka H, Muraki Y, Suzuki S (1994) Evaluation of 106 cases of scleritis in our hospital. Folia Ophthalmol Jpn 45:797e803","journal-title":"Folia Ophthalmol Jpn"},{"issue":"4","key":"124_CR29","first-page":"261","volume":"50","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Wang Z, Zhang Y et al (2014) Study on the clinical manifestation of 90 cases with scleritis and episcleritis. Zhonghua Yan Ke Za Zhi 50(4):261\u2013266","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"3","key":"124_CR30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5301\/ejo.5000394","volume":"24","author":"L Berchicci","year":"2014","unstructured":"Berchicci L, Miserocchi E, Di Nicola M et al (2014) Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center. Eur J Ophthalmol 24(3):293\u2013298","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"124_CR31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2012.08.005","volume":"120","author":"WG Wieringa","year":"2013","unstructured":"Wieringa WG, Wieringa JE, ten Dam-van Loon NH et al (2013) Visual outcome, treatment results, and prognostic factors in patients with scleritis. Ophthalmology 120(2):379\u2013386","journal-title":"Ophthalmology"},{"key":"124_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004397-198302310-00013","volume":"23","author":"M Cobo","year":"1983","unstructured":"Cobo M (1983) Inflammation of the sclera. Int Ophthalmol Clin 23:159\u2013171","journal-title":"Int Ophthalmol Clin"},{"key":"124_CR33","doi-asserted-by":"crossref","first-page":"493e501","DOI":"10.1097\/ICU.0b013e3282f06d2e","volume":"18","author":"KF Tabbara","year":"2007","unstructured":"Tabbara KF (2007) Tuberculosis. Curr Opin Ophthalmol 18:493e501","journal-title":"Curr Opin Ophthalmol"},{"key":"124_CR34","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","volume":"106","author":"PJ McCluskey","year":"1999","unstructured":"McCluskey PJ, Watson PG, Lightman S, Scleritis P et al (1999) Clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 106:2380\u20132386","journal-title":"Ophthalmology"},{"key":"124_CR35","first-page":"141","volume":"46","author":"EC Kim","year":"2006","unstructured":"Kim EC, Foster CS (2006) Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use. Int Ophthalmol Clin 46:141\u2013164","journal-title":"Int Ophthalmol Clin"},{"key":"124_CR36","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0161-6420(93)31473-9","volume":"100","author":"M Sainz de la Maza","year":"1993","unstructured":"Sainz de la Maza M, Jabbur NS, Foster CS (1993) An analysis of therapeutic decision for scleritis. Ophthalmology 100:1372\u20131376","journal-title":"Ophthalmology"},{"issue":"3","key":"124_CR37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509\u2013516","journal-title":"Am J Ophthalmol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-017-0124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12348-017-0124-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-017-0124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:36:17Z","timestamp":1498372577000},"score":1,"resource":{"primary":{"URL":"http:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-017-0124-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1186\/s12348-017-0124-5","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]},"article-number":"6"}}